A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Atara Biotherapeutics
Atara Biotherapeutics
Pierre Fabre Medicament
Pierre Fabre Medicament
SymBio Pharmaceuticals
Atara Biotherapeutics
Cell Medica Ltd
Cell Medica Ltd
RedHill Biopharma Limited